You have 9 free searches left this month | for more free features.

Virologic response

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Virologic Response in Participants Newly Diagnosed With HIV-1

Completed
  • HIV
  • Antiretroviral Therapy
  • Lisboa, Portugal
    Chlo - Hosp. Egas Moniz
Jan 17, 2023

HIV-1 Virologic Response Trial in Durban (DTP, ICM)

Completed
  • HIV-1 Virologic Response
  • DTP
  • ICM
  • Durban, South Africa
    TB HIV Care
Nov 18, 2022

Hepatitis C Trial in Lexington (PREP-C, Modified ECHO, Patient Telemedicine Questionnaire)

Completed
  • Hepatitis C
  • PREP-C
  • +2 more
  • Lexington, Kentucky
    University of Kentucky
Jan 31, 2023

About Anti-viral Regimen Adjustment on Achieving Complete

Unknown status
  • Sustained Virologic Response
  • Hepatitis B, Chronic
  • only monitoring
  • +2 more
  • Chongqing, Chongqing, China
    The second affiliated Hospital of Chongqing Medical University
Aug 4, 2021

Hepatitis B Trial in Worldwide (GSK3228836)

Recruiting
  • Hepatitis B
  • Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • +40 more
Jul 28, 2022

Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))

Terminated
  • Hepatitis C
  • Simeprivir (SMV)
  • +2 more
  • Denver, Colorado
    University of Colorado Denver (Leprino Building)
Aug 16, 2021

Hepatitis B Trial in Worldwide (JNJ-73763989, JNJ-56136379, Entecavir (ETV))

Active, not recruiting
  • Hepatitis B
  • Baltimore, Maryland
  • +9 more
Jan 17, 2023

HIV Trial in Baltimore (Lopinavir/Ritonavir)

Terminated
  • HIV
  • Baltimore, Maryland
    University of Maryland, Institute of Human Virology
Jan 20, 2022

HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR

Recruiting
  • Hepatitis C Virus Infection
  • +2 more
    • Douliu, Taiwan
    • +6 more
    Feb 23, 2021

    HCV Reinfection in HD Patients Achieving SVR

    Recruiting
    • Hepatitis C Virus Infection
    • +2 more
      • Douliu, Taiwan
      • +6 more
      Feb 22, 2021

      Human Immunodeficiency Virus-type 1 Infection Trial in Worldwide (Rilpivirine, Efavirenz, Tenofovir disoproxil fumarate)

      Completed
      • Human Immunodeficiency Virus-type 1 Infection
      • Douala, Cameroon
      • +17 more
      Jan 22, 2021

      Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir)

      Completed
      • Hepatitis C Virus Infection
      • Birmingham, Alabama
      • +137 more
      Mar 14, 2022

      Hepatitis B Trial in Worldwide (GSK3228836, PegIFN, NA therapy)

      Active, not recruiting
      • Hepatitis B
      • Sacramento, California
      • +48 more
      Jan 19, 2023

      Contributing Factors for Poor HIV Treatment Response in TB/HIV

      Recruiting
      • Tuberculosis
      • +2 more
      • Observational study
      • Kumasi, Ghana
        Kwame Nkrumah University of Science and Technology
      Mar 23, 2022

      T-bet B Cells in Persistent Virus Control After Discontinuance

      Completed
      • Chronic HBV Infection
      • Drug Withdrawal
      • T-bet B cell
      • Shanghai, China
        Changhai hospital
      Sep 1, 2023

      HIV Trial in Puerto Rico, Tanzania, United States (Lamivudine, Stavudine, Zidovudine)

      Completed
      • HIV Infections
      • Birmingham, Alabama
      • +39 more
      Oct 27, 2021

      Severe Mpox in Persons With Advanced HIV

      Recruiting
      • Monkeypox
      • +2 more
        • Atlanta, Georgia
          Centers for Disease Control and Prevention
        Sep 18, 2023

        Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)

        Completed
        • Hepatitis C, Chronic
        • PEGASYS 180 µg Q1W
        • +3 more
        • Changhua, Taiwan
        • +12 more
        Oct 7, 2021

        Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)

        Recruiting
        • Chronic Hepatitis C Virus
        • +4 more
        • Bucuresti, BUC, Romania
          Atea Study Site
        Jun 15, 2023

        Hepatitis C, HIV Coinfection Trial in Chennai (Low intensity HCV treatment adherence support, Medium intensity HCV treatment

        Recruiting
        • Hepatitis C
        • HIV Coinfection
        • Low intensity HCV treatment adherence support
        • +2 more
        • Chennai, Tamil Nadu, India
          YR Gaitonde Centre for AIDS Research and Education
        May 12, 2022

        Chronic Hepatitis B Trial in Worldwide (ABI-H0731, SOC NrtI)

        Terminated
        • Chronic Hepatitis B
        • Beverly Hills, California
        • +23 more
        Mar 22, 2022

        Hepatitis C Virus Trial (ABT-493/ABT-530)

        Completed
        • Hepatitis C Virus
        • (no location specified)
        Jul 9, 2021

        Hepatitis C, Chronic Trial in Albuquerque (HCV RNA screening)

        Terminated
        • Hepatitis C, Chronic
        • HCV RNA screening
        • Albuquerque, New Mexico
        • +1 more
        Oct 26, 2022

        HIV-1-infection Trial in Saint Louis (Biktarvy Tab)

        Terminated
        • HIV-1-infection
        • Biktarvy Tab
        • Saint Louis, Missouri
          Southampton Healthcare, Inc.
        Jan 3, 2023

        Coblopasvir Hydrochloride Capsules Combined With Sofosbuvir

        Not yet recruiting
        • Hepatitis C Infection
          • Beijing, Bejing, China
            Bejing Tsinghua Changgung Hospital
          Oct 31, 2022